PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Fluorescence Lifetime Imaging (FLIm) enables label-free characterization of tissue composition based on distinct spectral and temporal fluorescence signatures from biological samples. We leverage a database of intraluminal FLIm-IVUS imaging data associated with histological findings to demonstrate the detection of foam cells(540-nm lifetime increase, ROC-AUC=0.94 for foam cell infiltration >25%), superficial calcium (450-nm lifetime decrease), and regions of active plaque formation (390-nm lifetime increase). The ability of FLIm to provide information that complements existing intravascular imaging modalities opens new perspectives to improve our understanding of plaque development and improve risk assessment in patients at risk of acute coronary events.
Julien Bec,Deborah vela M.D.,L. Maximilian Buja M.D.,Kenneth B. Margulies M.D., andLaura Marcu
"Label-free assessment of biochemical markers of atherosclerotic plaque progression using intravascular fluorescence lifetime", Proc. SPIE 11621, Diagnostic and Therapeutic Applications of Light in Cardiology 2021, 116210N (5 March 2021); https://doi.org/10.1117/12.2579155
ACCESS THE FULL ARTICLE
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Julien Bec, Deborah vela M.D., L. Maximilian Buja M.D., Kenneth B. Margulies M.D., Laura Marcu, "Label-free assessment of biochemical markers of atherosclerotic plaque progression using intravascular fluorescence lifetime," Proc. SPIE 11621, Diagnostic and Therapeutic Applications of Light in Cardiology 2021, 116210N (5 March 2021); https://doi.org/10.1117/12.2579155